Preston, Alexandra E. https://orcid.org/0000-0003-0008-5916
Frost, Joe N. https://orcid.org/0000-0002-5946-6062
Teh, Megan R. https://orcid.org/0000-0002-8095-9961
Badat, Mohsin https://orcid.org/0000-0003-0744-5427
Armitage, Andrew E. https://orcid.org/0000-0001-5977-6602
Norfo, Ruggiero
Wideman, Sarah K. https://orcid.org/0000-0001-7803-9894
Hanifi, Muhammad
White, Natasha https://orcid.org/0000-0001-5793-892X
Roy, Noémi BA.
Babbs, Christian https://orcid.org/0000-0002-1898-5878
Ghesquiere, Bart https://orcid.org/0000-0003-1547-1705
Davies, James https://orcid.org/0000-0002-4108-4357
Howden, Andrew JM.
Sinclair, Linda V. https://orcid.org/0000-0003-1248-7189
Hughes, Jim R. https://orcid.org/0000-0002-8955-7256
Kassouf, Mira https://orcid.org/0000-0002-9781-921X
Beagrie, Rob https://orcid.org/0000-0003-1076-5595
Higgs, Douglas R. https://orcid.org/0000-0003-3579-8705
Drakesmith, Hal https://orcid.org/0000-0002-8503-6103
Funding for this research was provided by:
RCUK | MRC | Medical Research Foundation
Article History
Received: 29 January 2024
Accepted: 28 February 2025
First Online: 24 March 2025
Competing interests
: J.D. and J.H. are co-founders and board members of Nucleome Therapeutics and they provide consultancy to the company. This had no influence on the research presented in this study. The remaining authors declare no competing interests.